GB935405A - Anthranilic acid derivatives and methods for producing same - Google Patents
Anthranilic acid derivatives and methods for producing sameInfo
- Publication number
- GB935405A GB935405A GB22728/61A GB2272861A GB935405A GB 935405 A GB935405 A GB 935405A GB 22728/61 A GB22728/61 A GB 22728/61A GB 2272861 A GB2272861 A GB 2272861A GB 935405 A GB935405 A GB 935405A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dimethylphenyl
- chloride
- prepared
- formula
- yield
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 239000002253 acid Substances 0.000 abstract 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 abstract 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- CCEUHFFHFAHLPS-UHFFFAOYSA-N N-(2,3-dimethylphenyl)benzenecarboximidoyl chloride Chemical compound CC1=C(C=CC=C1C)N=C(C1=CC=CC=C1)Cl CCEUHFFHFAHLPS-UHFFFAOYSA-N 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 239000003085 diluting agent Substances 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 2
- 229960001047 methyl salicylate Drugs 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 abstract 2
- GMTYWRUVJSPUDR-UHFFFAOYSA-N (2-cyanophenyl) N-(2,3-dimethylphenyl)benzenecarboximidate Chemical compound CC1=C(C=CC=C1C)N=C(C1=CC=CC=C1)OC1=C(C=CC=C1)C#N GMTYWRUVJSPUDR-UHFFFAOYSA-N 0.000 abstract 1
- RRGZCPBAIVCVTA-UHFFFAOYSA-N 1-ethyl-2-methyl-3-nitrobenzene Chemical compound CCC1=CC=CC([N+]([O-])=O)=C1C RRGZCPBAIVCVTA-UHFFFAOYSA-N 0.000 abstract 1
- ZVAKFJFOGUFJON-UHFFFAOYSA-N 1-iodo-2-methyl-3-nitrobenzene Chemical compound CC1=C(I)C=CC=C1[N+]([O-])=O ZVAKFJFOGUFJON-UHFFFAOYSA-N 0.000 abstract 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 abstract 1
- VVAKEQGKZNKUSU-UHFFFAOYSA-N 2,3-dimethylaniline Chemical compound CC1=CC=CC(N)=C1C VVAKEQGKZNKUSU-UHFFFAOYSA-N 0.000 abstract 1
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 abstract 1
- CHZCERSEMVWNHL-UHFFFAOYSA-N 2-hydroxybenzonitrile Chemical compound OC1=CC=CC=C1C#N CHZCERSEMVWNHL-UHFFFAOYSA-N 0.000 abstract 1
- GDJLLPTUSIUMOM-UHFFFAOYSA-N 3-ethyl-2-methylaniline Chemical compound CCC1=CC=CC(N)=C1C GDJLLPTUSIUMOM-UHFFFAOYSA-N 0.000 abstract 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- CPNDDAVUGJYGLC-UHFFFAOYSA-N N-(2,3-dimethylphenyl)-2,2-dimethylpropanimidoyl chloride Chemical compound CC1=C(C=CC=C1C)N=C(C(C)(C)C)Cl CPNDDAVUGJYGLC-UHFFFAOYSA-N 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 230000002917 arthritic effect Effects 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 150000002463 imidates Chemical class 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 229910052751 metal Chemical group 0.000 abstract 1
- 239000002184 metal Chemical group 0.000 abstract 1
- CDALOPCMGNOMMK-UHFFFAOYSA-N methyl 2-(n-benzoyl-2,3-dimethylanilino)benzoate Chemical compound COC(=O)C1=CC=CC=C1N(C=1C(=C(C)C=CC=1)C)C(=O)C1=CC=CC=C1 CDALOPCMGNOMMK-UHFFFAOYSA-N 0.000 abstract 1
- HPFJHWNLSAQNSC-UHFFFAOYSA-N methyl 2-[N-(2,2-dimethylpropanoyl)-2,3-dimethylanilino]benzoate Chemical compound COC(C=1C(N(C2=C(C(=CC=C2)C)C)C(C(C)(C)C)=O)=CC=CC1)=O HPFJHWNLSAQNSC-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- IJUIRQSZLUOHLO-UHFFFAOYSA-N n-(2,3-dimethylphenyl)-2,2-dimethylpropanamide Chemical compound CC1=CC=CC(NC(=O)C(C)(C)C)=C1C IJUIRQSZLUOHLO-UHFFFAOYSA-N 0.000 abstract 1
- 239000012299 nitrogen atmosphere Substances 0.000 abstract 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 230000000552 rheumatic effect Effects 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 abstract 1
- 229910000104 sodium hydride Inorganic materials 0.000 abstract 1
- 239000012312 sodium hydride Substances 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000001117 sulphuric acid Substances 0.000 abstract 1
- 235000011149 sulphuric acid Nutrition 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
- C07C229/58—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position having the nitrogen atom of at least one of the amino groups further bound to a carbon atom of a six-membered aromatic ring, e.g. N-phenyl-anthranilic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38097A US3138636A (en) | 1960-06-23 | 1960-06-23 | Anthranilic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB935405A true GB935405A (en) | 1963-08-28 |
Family
ID=21898074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB22728/61A Expired GB935405A (en) | 1960-06-23 | 1961-06-22 | Anthranilic acid derivatives and methods for producing same |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3138636A (cg-RX-API-DMAC7.html) |
| CH (2) | CH401991A (cg-RX-API-DMAC7.html) |
| CY (1) | CY284A (cg-RX-API-DMAC7.html) |
| DE (1) | DE1163846B (cg-RX-API-DMAC7.html) |
| ES (1) | ES268517A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR1315030A (cg-RX-API-DMAC7.html) |
| GB (1) | GB935405A (cg-RX-API-DMAC7.html) |
| MY (1) | MY6400104A (cg-RX-API-DMAC7.html) |
| NL (1) | NL123121C (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002018319A1 (en) * | 2000-08-25 | 2002-03-07 | Warner-Lambert Company Llc | Process for making n-aryl-anthranilic acids and their derivatives |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH479599A (de) * | 1965-04-12 | 1969-10-15 | Bristol Myers Co | Verfahren zur Herstellung von Verbindungen von Nitrilen mit Stickstoffwasserstoffsäure oder Aziden |
| US5789444A (en) * | 1995-10-06 | 1998-08-04 | Washington University | Method of reducing glutamate neurotoxicity with anthranilic acid derivatives |
| US7345051B2 (en) * | 2000-01-31 | 2008-03-18 | Genaera Corporation | Mucin synthesis inhibitors |
| AU2019348194B2 (en) | 2018-09-28 | 2025-04-03 | Griffith University | Agents and methods for modulating pathogen activity |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2006735A (en) * | 1932-11-17 | 1935-07-02 | Gen Aniline Works Inc | Nitro-aryl amino-aryl amines |
-
1960
- 1960-06-23 US US38097A patent/US3138636A/en not_active Expired - Lifetime
-
1961
- 1961-06-22 NL NL266264A patent/NL123121C/xx active
- 1961-06-22 DE DEP27407A patent/DE1163846B/de active Pending
- 1961-06-22 CH CH731161A patent/CH401991A/fr unknown
- 1961-06-22 GB GB22728/61A patent/GB935405A/en not_active Expired
- 1961-06-22 ES ES0268517A patent/ES268517A1/es not_active Expired
- 1961-06-22 CH CH1440365A patent/CH405349A/fr unknown
- 1961-06-22 FR FR865809A patent/FR1315030A/fr not_active Expired
-
1964
- 1964-04-06 CY CY28464A patent/CY284A/xx unknown
- 1964-12-31 MY MY1964104A patent/MY6400104A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002018319A1 (en) * | 2000-08-25 | 2002-03-07 | Warner-Lambert Company Llc | Process for making n-aryl-anthranilic acids and their derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1163846B (de) | 1964-02-27 |
| CH401991A (fr) | 1965-11-15 |
| NL123121C (cg-RX-API-DMAC7.html) | 1967-10-16 |
| ES268517A1 (es) | 1962-05-01 |
| NL266264A (cg-RX-API-DMAC7.html) | 1964-09-10 |
| FR1315030A (fr) | 1963-01-18 |
| CY284A (en) | 1964-04-06 |
| MY6400104A (en) | 1964-12-31 |
| CH405349A (fr) | 1966-01-15 |
| US3138636A (en) | 1964-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102516122B (zh) | 制备邻羟基苯甲腈的dmf溶液的方法 | |
| ES268517A1 (es) | Un procedimiento para la producciën de nuevos acidos antranilicos | |
| Schmelkes et al. | Substituted p-aminobenzoic acids | |
| GB964143A (en) | Substituted quinolines | |
| US2498497A (en) | 2[2(phthalimido)ethyl]pyridines | |
| ES421067A1 (es) | Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas. | |
| GB823191A (en) | New phenthiazine derivatives and processes for their preparation | |
| GB1088295A (en) | Derivatives of alkanoic acids and methods for their preparation | |
| GB921315A (en) | The manufacture of 8-aminoalkylamino quinoline derivatives | |
| JPS54138586A (en) | Preparation of isocyanuric acid ester | |
| GB1082184A (en) | Thiamine derivatives | |
| GB930477A (en) | Anthranilic acid derivatives and methods for producing same | |
| Westby et al. | Acridan-4-carboxylic acids and N-aryl-2-amino-3-toluic acids as planar and antiplanar analogs of antiinflammatory N-arylanthranilic acids | |
| US2615895A (en) | Sxyxcooh | |
| GB778936A (en) | Improvements relating to n-aminoalkyl derivatives of substituted iminodibenzyls | |
| US2390593A (en) | Dicarboxylic acid derivatives of lower alkyl ethers of vitamin b6, and a process of peparing the same | |
| GB673413A (en) | New local anaesthetics which are substituted benzoic esters and processes for making the same | |
| ES260505A1 (es) | Un procedimiento para la producciën de compuestos de benzamida | |
| GB974744A (en) | New 4-substituted 1,2-diaryl-3,5-dioxopyrazolidines and processes for preparing same | |
| GB1381128A (en) | Anthranilic acid derivative | |
| GB738676A (en) | New 2-substituted benzthiazole compounds and silver halide emulsions containing them | |
| GB981533A (en) | Derivatives of phenylalanine | |
| GB1000803A (en) | New uracil derivatives and process for their production | |
| GB1001356A (en) | Substituted anthranilic acid esters | |
| GB840341A (en) | Process for the manufacture of di-imidazole derivatives |